The results indicated that the level of PLOD3 in the serum of CRC patients was significantly higher than that in the serum of healthy individuals (Fig. 8I), moreover, III + IV tumor stage group showed higher PLOD3 concentration in serum (Fig. 8J). This evidence concerns the gene PLOD3 and neoplasm.